National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items – Subsection 99ACA(3) Determination 2017

Administered by Department of Health, Disability and Ageing

Legislation au F2017L01259 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

INSTRUMENT NUMBER PB 82 OF 2017

 

NATIONAL HEALTH ACT 1953

National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items – Subsection 99ACA(3) Determination 2017

Authority and Operation

This legislative instrument is made pursuant to section 99ACA(3) of the National Health Act 1953 (the Act) to determine a class of pharmaceutical items that are deemed to have been subjected to an administrative 12.5% price reduction.

This is to reflect those administrative price reductions that applied to certain pharmaceutical items prior to 1 August 2007, being the commencement of the National Health Amendment (Pharmaceutical Benefits Scheme) Act 2007, which codified the 12.5% reduction through the creation of section 99ACB of the Act.

This Instrument revokes and replaces the Determination under subsection 99ACA(3) of the National Health Act 1953 (PB 59 of 2007).

This Instrument commences on the day of registration on the Federal Register of Legislation.

Purpose

Section 99ACA is a definitional section for the purposes of Division 3A of the Act. Division 3A is concerned with statutory price reductions for listed brands of pharmaceutical items.

A determination under section 99ACA(3) is needed to ensure that those pharmaceutical items that have previously taken a 12.5% administrative price reduction are not also subjected to a further price reduction under section 99ACB.

Section 99ACB(2) states that there are no further price reductions to those drugs identified as being “in a class of pharmaceutical items to which a 12.5% administrative price reduction has applied”. 

This Instrument determines the classes of pharmaceutical items to which a 12.5% administrative price reduction has applied, defining the relevant class for the purpose of section 99ACB(2).

Schedule 1 sets out the determined classes of pharmaceutical items, by drug and manner of administration.

Consultation

Consultation was conducted when this Instrument was initially made. No further consultation was required.

General

This instrument is a legislative instrument for the purposes of the Legislation Act 2003.

 


Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.